News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
217 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17680)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (309)
2 (217)
3 (119)
4 (10)
5 (15)
6 (240)
7 (330)
8 (243)
9 (293)
10 (101)
11 (2)
12 (13)
13 (228)
14 (250)
15 (299)
16 (255)
17 (104)
18 (5)
19 (7)
20 (208)
21 (277)
22 (218)
23 (219)
24 (80)
25 (4)
26 (9)
27 (24)
28 (229)
29 (306)
30 (261)
31 (124)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Acclaimed Medical Journal, PLOS Medicine, Publishes Study Scientifically Backing bistroMD Core Philosophy
Recent Tufts University Study Explains Food is the Most Powerful Medicine and Outlines the Economic Benefits Gained by Healthy Eating
May 2, 2019
·
3 min read
Job Trends
Non-Profit Digital Innovation for Mental Health Awareness Month
“May is Mental Health Month” marks 70 years in 2019. Humans Helping Humans is a 501 (c)(3) non-profit that positively impacts mental health awareness and innovative change releases their big plans for spreading awareness and giving back in May.
May 2, 2019
·
2 min read
Policy
Transport Canada continues to improve the safe transportation of dangerous goods by rail
To protect the safety and security of Canadians, especially those along our rail corridors, it is important that the transportation of dangerous goods by rail be done as safely as possible.
May 2, 2019
·
2 min read
Pharm Country
Nuvolo Recognized by ServiceNow
Fastest Growing ISV Globally Delivers Record Store Revenue with Modern Facilities Management and IWMS Enterprise Software Built Natively on ServiceNow
May 2, 2019
·
2 min read
Pharm Country
TNG Announces the Newly Redesigned Websites of ATIXA, the Association of Title IX Administrators and NaBITA, the National Behavioral Intervention Team Association
TNG, the management company for the membership associations ATIXA and NaBITA, is pleased to announce the launch of its newly redesigned sites atixa.org and nabita.org!
May 2, 2019
·
2 min read
Job Trends
Mental Health Experts Focus Their Efforts on Men
Let’s Talk Campaign Highlights Challenges Men Face to Positive Mental Health
May 2, 2019
·
2 min read
Pharm Country
Glenmark Therapeutics Expands Specialty Portfolio with OTIPRIO® Co-Promotion Agreement in the U.S. with Otonomy for Acute Otitis Externa Indication
Glenmark Therapeutics Inc., USA announced a co-promotion agreement with Otonomy, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology.
May 2, 2019
·
6 min read
Deals
CannTrust Announces Pricing of Public Offering of Common Shares
CannTrust Holdings Inc. announced the pricing of its previously-announced underwritten public offering of 36,363,636 common shares at a price to the public of US$5.50 per share.
May 2, 2019
·
6 min read
FDA
Ivantis Announces Groundbreaking 3 Year Results from FDA Clinical Trial; First Device in Minimally Invasive Glaucoma Surgical (MIGS) Category to Demonstrate Significant Long Term Reduction of Severe Major Surgeries for Glaucoma Patients
First study of any kind showing a MIGS device achieving a statistically significant reduction in secondary incisional surgery; over 70% of patients remain free of medications
May 2, 2019
·
8 min read
Business
Nanosonics to Showcase Innovative trophon2 at ACOG 2019 Annual Meeting
HLD solution proven to reduce risk of ultrasound probe cross-infection without harm to environment
May 2, 2019
·
3 min read
Previous
9 of 22
Next